“Treatment Retention and Hemoglobin Response During Darbepoetin Alfa and Recombinant Human Erythropoietin Beta Therapy in Children With CKD-Related Anemia: A Secondary Analysis of a Randomized Trial” (2026) The Planet, 10(03), pp. 1103–1106. doi:10.5281/zenodo.23912066.